Changes to Biohit Oyj’s management
02.05.2012 09:30
INTERIM REPORT OF THE BIOHIT GROUP 1 JANUARY TO 31 MARCH 2012
26.04.2012 09:30
Biohit HealthCare's unique GastroPanel examinations diagnose diseases of the stomach
and the risks associated with these diseases. Our quick tests provide diagnosis
of lactose intolerance and Helicobacter
pylori infection, as well as fecal occult blood, a well-known marker for
colorectal cancer. Instruments for analysing the test results are also available in our product range.
The new over-the-counter products eliminate carcinogenic acetaldehyde thus reducing the risk of cancers of the gastrointestinal tract.
Biohit Oyj sold its liquid handling segment to Sartorius Lab Holding GmbH in December 2011. Read more about Sartorius Biohit Liquid Handling Oy.